Compile Data Set for Download or QSAR
Report error Found 81 Enz. Inhib. hit(s) with all data for entry = 50001938
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50248008(CHEBI:473990 | BMS-200475-01 | Baraclude | Entecav...)
Affinity DataEC50:  0.240nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  1nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247811(CHEMBL4078766)
Affinity DataEC50:  3nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247657(CHEMBL4076401)
Affinity DataEC50:  5nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450818(CHEMBL4211812)
Affinity DataEC50:  6nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450790(CHEMBL4210470)
Affinity DataEC50:  10nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  10nMAssay Description:Inhibition of reverse transcriptase M204I mutant expressing telbivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells assessed as r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  11nMAssay Description:Inhibition of reverse transcriptase M204I mutant expressing lamivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells assessed as re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  12nMAssay Description:Inhibition of telbivudine-resistant wild type hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in intracellular DNA levels...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  12nMAssay Description:Inhibition of reverse transcriptase M204I/S202G double mutant expressing entecavir-resistant hepatitis B virus capsid assembly in human Huh7 cells as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  14nMAssay Description:Inhibition of wild type hepatitis B virus capsid assembly in human HepG2.215 cells assessed as reduction in intracellular DNA levels measured on day ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  15nMAssay Description:Inhibition of reverse transcriptase M204I/V173L double mutant expressing lamivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247656(CHEMBL4062770)
Affinity DataEC50:  16nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  17nMAssay Description:Inhibition of wild type hepatitis B virus capsid assembly in human HepG2.215 cells assessed as reduction in intracellular DNA levels measured on day ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  18nMAssay Description:Inhibition of reverse transcriptase M204I/S202G/M250V triple mutant expressing entecavir-resistant hepatitis B virus capsid assembly in human Huh7 ce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  19nMAssay Description:Inhibition of reverse transcriptase M204I/VI73L double mutant expressing lamivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  19nMAssay Description:Inhibition of reverse transcriptase L180M/M204V double mutant expressing telbivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247733(CHEMBL4079561)
Affinity DataEC50:  20nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  20nMAssay Description:Inhibition of telbivudine-resistant wild type hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in secreted DNA levels meas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  20nMAssay Description:Inhibition of lamivudine-resistant wild type hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in secreted DNA levels measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450781(CHEMBL4205737)
Affinity DataEC50:  26nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  31nMAssay Description:Inhibition of wild type hepatitis B virus capsid assembly in human HepG2.215 cells assessed as reduction in intracellular DNA levels measured on day ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  33nMAssay Description:Inhibition of reverse transcriptase L180M/M204V double mutant expressing telbivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  34nMAssay Description:Inhibition of wild type hepatitis B virus capsid assembly in human HepG2.215 cells assessed as reduction in intracellular DNA levels measured on day ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  34nMAssay Description:Inhibition of entecavir-resistant wild type hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in secreted DNA levels measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  34nMAssay Description:Inhibition of lamivudine-resistant wild type hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in intracellular DNA levels ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247735(CHEMBL4075908)
Affinity DataEC50:  35nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  38nMAssay Description:Inhibition of wild type hepatitis B virus capsid assembly in human HepG2.215 cells assessed as reduction in intracellular DNA levels measured on day ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  39nMAssay Description:Inhibition of entecavir-resistant wild type hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in intracellular DNA levels m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247801(CHEMBL4070728)
Affinity DataEC50:  42nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  46nMAssay Description:Inhibition of reverse transcriptase M204I/S202G/M250V triple mutant expressing entecavir-resistant hepatitis B virus capsid assembly in human Huh7 ce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50278715(BAY-414109 | CHEMBL605300)
Affinity DataEC50:  48nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247734(CHEMBL4077161)
Affinity DataEC50:  69nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450789(CHEMBL4206627)
Affinity DataEC50:  74nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450791(CHEMBL4216331)
Affinity DataEC50:  80nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50001103(9-[2-phosphonomethoxyethyl]adenine | 9-(2-(phospho...)
Affinity DataEC50:  83nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  87nMAssay Description:Inhibition of reverse transcriptase M204I/S202G double mutant expressing entecavir-resistant hepatitis B virus capsid assembly in human Huh7 cells as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  92nMAssay Description:Inhibition of reverse transcriptase M204I mutant expressing telbivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells assessed as r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247812(CHEMBL3742114)
Affinity DataEC50:  92nMAssay Description:Inhibition of reverse transcriptase M204I mutant expressing lamivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells assessed as re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247655(CHEMBL4103602)
Affinity DataEC50:  100nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450782(CHEMBL4209011)
Affinity DataEC50:  100nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450814(CHEMBL3121560)
Affinity DataEC50:  100nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450811(CHEMBL4214974)
Affinity DataEC50:  150nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450784(CHEMBL4217281)
Affinity DataEC50:  200nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450813(CHEBI:63625 | Atripla | GS-1275 | PMP-A | Tenofovi...)
Affinity DataEC50:  242nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450792(CHEMBL4204130)
Affinity DataEC50:  250nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450812(CHEMBL4208714)
Affinity DataEC50:  250nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50247659(CHEMBL4064808)
Affinity DataEC50:  500nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50450797(CHEMBL4203418)
Affinity DataEC50:  800nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetCapsid protein(HBV)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50088372(CHEBI:63624 | NV-02B | Sebivo | Telbivudine | Tyze...)
Affinity DataEC50:  819nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 81 total ) | Next | Last >>
Jump to: